1. PRRT Practical Resources
  2. PRRT Practical Resources
  3. Service Development Toolkit
  4. Service Development Toolkit - Introduction

Prescribing information

Service Development Toolkit - Introduction

Toolkit Introduction

Optimising personalised care is a key component of the NHS Long Term Plan and has the potential to provide better outcomes for patients in addition to more effective and joined-up services. Therefore, it is important that patients are supported in making choices that reflect what they value most.1

This toolkit has been developed with support from UK healthcare professionals to explore how the treatment of NETs can be delivered efficiently within current guidelines and tailored to the needs of patients.

The toolkit provides examples of service models in different settings, and resources to help you to incorporate aspects of these pathways into your own service.

 

Click on the links below for an introduction to the toolbox, relevant guidelines and resources.

 

Toolkit Introduction

Introduction to NHS Oncology Policy

Nuclear Medicine Guidelines

NETs Clinical Guidelines

 

Reference
1. NHS. NHS Long Term Plan. 2019. Available at: https://www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term... (Accessed April 2020).
AAA-Lu177-UK-2232 | October 2023

Starter Pack

Starter Pack

Guidance and resources on setting up a delivery service for Lutathera® for patients with neuroendocrine tumours (NETs), including service set-up, Lutathera® information, including product administration, and information on patient management.

... Show more
AAA-Lu177-UK-2196 | December 2023

Case Studies

Case Studies

A selection of case studies describing initiatives optimising the management of patients with NETs receiving molecular radiotherapy.

Show more
AAA-Lu177-UK-2236 | October 2023
Image of global with network nodes

Update from ECE 2021

Watch the Advanced Accelerator Applications satellite symposium from the 23rd European Congress of Endocrinology (ECE) virtual congress, "Timing is everything: Early intervention with LUTATHERA® (lutetium [177Lu] oxodotreotide) following progression in

... Show more
AAA-Lu177-UK-2006 | June 2023
Image of people's hands together in a huddle

Further support

Further support

Access a list of direct links to some of the most useful resources from medical societies, patient groups and other education providers.

Show more
AAA-Lu177-UK-1666 | March 2023
×

Ask Speakers

×

Medical Information Request